lobbying_activities: 1223492

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1223492	00463677-6915-4258-848e-a5ab844799a8	Q1	ACG ADVOCACY	2057	GENENTECH INC	2012	first_quarter	HCR	Prescription Drug User Fee Act (PDUFA) Reauthorization Avastin - Use in breast cancer treatment ASP+6 Reimbursement Issues Melanoma Research Foundation Hill event	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2012-04-04T17:43:30.180000-04:00